Livalo and Lymphoma - a phase IV clinical study of FDA data

Summary:

Lymphoma is reported as a side effect among people who take Livalo (pitavastatin calcium), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Zetia, and have High blood pressure.

The phase IV clinical study analyzes which people have Lymphoma when taking Livalo. It is created by eHealthMe based on reports of 8,536 people who have side effects when taking Livalo from the FDA, and is updated regularly.

What is Livalo?

Livalo has active ingredients of pitavastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 8,802 Livalo users. Check the latest studies of Livalo.

What is Lymphoma?

Lymphoma (cancer that begins in immune system cells) is found to be associated with 961 drugs and 1,015 conditions by eHealthMe. Check the latest studies of Lymphoma.

On Jul, 16, 2026

8,536 people reported to have side effects when taking Livalo.
Among them, 25 people (0.29%) have Lymphoma.

Among these 25 people:

How long have people been on Livalo when they have Lymphoma? *

What is the gender of people who have Lymphoma when taking Livalo? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Lymphoma when taking Livalo? *

What are other drugs people take besides Livalo? *

What are other side effects people have besides Lymphoma? *

Pain In Extremity: 8 people, 32.00%
Immunosuppressant Drug Level Decreased: 7 people, 28.00%
Excessive Granulation Tissue (excessive collagen-rich tissue which forms at the site of an injury): 7 people, 28.00%
Leukopenia (less number of white blood cells in blood): 7 people, 28.00%
Epstein-Barr Virus Infection: 7 people, 28.00%
Echocardiogram Abnormal: 7 people, 28.00%
Rashes (redness): 7 people, 28.00%
Heart Transplant Rejection: 7 people, 28.00%
Feeling Hot: 7 people, 28.00%
Cytomegalovirus Infection: 7 people, 28.00%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 48.00%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 24.00%
Immunodeficiency Common Variable: 5 people, 20.00%
Constipation: 3 people, 12.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 12.00%
Type 2 Diabetes: 3 people, 12.00%
Osteoporosis (bones weak and more likely to break): 2 people, 8.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.00%
Diabetes: 2 people, 8.00%
Insomnia (sleeplessness): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Livalo and have Lymphoma?

- Check whether Lymphoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Livalo:

Livalo (8,802 reports)

Lymphoma treatments and more:

Lymphoma (33,395 reports)

Browse all side effects of Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphoma:

Lymphoma (961 drugs)

Browse all the conditions that are associated with Lymphoma:

Lymphoma (1,015 conditions)

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .

How the study uses the data?

The study uses data from the FDA. It is based on pitavastatin calcium (the active ingredients of Livalo) and Livalo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.